These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7780376)

  • 1. Synthesis and in vivo disposition studies of 18F-labeled HFA-134a.
    Finch JR; Banks WR; Hwang DR; Satter MR; Ezzidene B; Mantil JC; Digenis GA
    Appl Radiat Isot; 1995 Apr; 46(4):241-8. PubMed ID: 7780376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic monitoring of total-body absorption by 19F NMR spectroscopy: one hour ventilation of HFA-134a in male and female rats.
    Finch JR; Dadey EJ; Smith SL; Harrison LI; Digenis GA
    Magn Reson Med; 1995 Mar; 33(3):409-13. PubMed ID: 7760708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFA-134a (1,1,1,2-tetrafluoroethane): effects of inhalation exposure upon reproductive performance, development and maturation of rats.
    Alexander DJ; Libretto SE; Adams MJ; Hughes EW; Bannerman M
    Hum Exp Toxicol; 1996 Jun; 15(6):508-17. PubMed ID: 8793535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG; Millar AB; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure.
    Emmen HH; Hoogendijk EM; Klöpping-Ketelaars WA; Muijser H; Duistermaat E; Ravensberg JC; Alexander DJ; Borkhataria D; Rusch GM; Schmit B
    Regul Toxicol Pharmacol; 2000 Aug; 32(1):22-35. PubMed ID: 11029265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the chlorofluorocarbon substitute 1,1,1,2-tetrafluoroethane (HFA-134a) in human and animal blood using gas chromatography with headspace analysis.
    Cooper KM; Chang SF; Harrison LI
    J Chromatogr B Biomed Appl; 1995 May; 667(1):85-93. PubMed ID: 7663689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFA-134a (1,1,1,2-tetrafluoroethane); lack of oncogenicity in rodents after inhalation.
    Alexander DJ; Libretto SE; Chevalier HJ; Imamura T; Pappritz G; Wilson J
    Hum Exp Toxicol; 1995 Sep; 14(9):706-14. PubMed ID: 8579880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
    Shin HW; Barletta B; Yoonessi L; Meinardi S; Leu SY; Radom-Aizik S; Randhawa I; Nussbaum E; Blake DR; Cooper DM
    Clin Transl Sci; 2015 Oct; 8(5):445-50. PubMed ID: 26155923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects.
    Harrison LI; Donnell D; Simmons JL; Ekholm BP; Cooper KM; Wyld PJ
    J Pharm Pharmacol; 1996 Jun; 48(6):596-600. PubMed ID: 8832493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).
    Alexander DJ; Libretto SE
    Hum Exp Toxicol; 1995 Sep; 14(9):715-20. PubMed ID: 8579881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of omega-[18F]fluoroalkyl analogs of YM-09151-2 for the measurement of D2-dopamine receptors with PET.
    Hatano K; Ido T; Ishiwata K; Hatazawa J; Itoh M; Kawashima K; Iwata R
    Int J Rad Appl Instrum A; 1990; 41(6):551-5. PubMed ID: 2163373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure.
    Gunnare S; Ernstgård L; Sjögren B; Johanson G
    Toxicol Lett; 2006 Nov; 167(1):54-65. PubMed ID: 17030466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP; Lundback B; Yigla M; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute, repeated inhalation toxicity, respiratory system irritation, and mutagenicity studies of 1,1,2,2-tetrafluoroethane (HFC-134) as the impurity in the pharmaceutical propellant 1,1,1,2-tetrafluoroethane (HFA-134a).
    Zhao Y; Sun H; Lin F; Yang H
    Drug Chem Toxicol; 2023 Nov; 46(5):841-850. PubMed ID: 35920286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.